Poland· PL-100033930
PoltechMBrIDA
A 99m-tc-technetium-mebrofenin product containing technetii (99mtc) mebrofenini, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
99m-tc-technetium-mebrofenin is registered in 5 of 19 countries.
Countries holding a registration under ATC V09DA04 (99m-tc-technetium-mebrofenin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
99m-tc-technetium-mebrofenin · ATC V09DA04
5 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Technetii (99mTc) mebrofenini
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09DA04
- ATC class
- 99m-Tc-Technetium-Mebrofenin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990327010
- gtin05909990327027
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for 99m-tc-technetium-mebrofenin.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
99m-tc-technetium-mebrofenin · interactions on record
6 records
- 6 moderate
Most severe, free to view
- OpiumA07DA02moderate
- MorphineN02AA01moderate
- OpiumN02AA02moderate
- MorphinN07BC09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V09DA04
99m-tc-technetium-mebrofenin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ee33893-848f-49bf-a8b6-0b51d5074bd8 GET /v1/drugs/5ee33893-848f-49bf-a8b6-0b51d5074bd8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Liofilizat do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "20 mg MBrIDA",
"packaging": "Lz ¦ Skasowane ¦ 5309\n1 zestaw \n05909990327010 ¦ Lz ¦ 16458\n3 fiol. liof.\n05909990327027 ¦ Lz ¦ 16459\n6 fiol. liof.",
"substance": "MBrIDA 20 mg",
"common_name": "Technetii (99mTc) mebrofenini",
"pl_product_id": "100033930",
"pozwolenie_nr": "03270",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about 99m-tc-technetium-mebrofenin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.